Don’t miss those “my dog did the most amazing thing” moments.
We believe everyone in the family should have access to the best healthcare. So we formed BioTesserae to bring cutting edge cancer therapies to our four-legged family members.
Breakthroughs come from unlikely sources.
Meet the Team:
We are a group of dedicated clinicians and scientists that share the same goal of providing cutting-edge therapies to our pets in need.
-
Patrick Iversen, PhD
CEO
-
Shay Bracha, DVM
Co-Founder
-
Chris Cebra, VMD
Co-Founder
-
Dan Mourich, PhD
Co-Founder
-
Carl Ruby, PhD
Co-Founder
Our Partners:
-
Expert Dojo
-
Advantage Accelerator
-
Sunflower Therapeutics
-
Systemic Innovations
-
Consultants for Veterinary Biologics
“He was like my mini-me. And he enjoyed stealing roast chickens off the kitchen counter!” -Genevieve
Press & Publications:
-
May 13, 2023
Veterinary Sciences
Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology
-
September 7, 2022
-
August 25, 2022
Oregon State University Newsroom,
NSF grant to OSU researchers will aid development of antibody treatment for dogs with cancer
-
February 2022
Frontiers in Chemistry,
Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins
-
Winter 2019
-
October 24, 2019
Contact us.
-
HP Campus Building 11
1110 NE Circle Blvd
Corvallis, OR. 97330
leadership@biotesserae.com
-
Help make diseases like cancer a thing of the past and donate to cutting edge research.
-
We would love to hear about an “amazing thing” that your fuzzy friend just did.
Biotesserae@gmail.com